MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L‐like during epithelial‐mesenchymal transition-Reference-Cited by-同舟云学术

MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L‐like during epithelial‐mesenchymal transition

Published:2021-07-29 Issue:9 Volume:112 Page:3846-3855
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sakuma Keiichiro¹,Sasaki Eiichi²,Hosoda Waki²,Komori Koji³,Shimizu Yasuhiro³,Yatabe Yasushi⁴^ORCID,Aoki Masahiro¹⁵^ORCID

Affiliation:

1. Division of Pathophysiology Aichi Cancer Center Research Institute Nagoya Japan

2. Department of Pathology and Molecular Diagnostics Aichi Cancer Center Hospital Nagoya Japan

3. Department of Gastroenterological Surgery Aichi Cancer Center Hospital Nagoya Japan

4. Department of Diagnostic Pathology National Cancer Center Hospital Tokyo Japan

5. Department of Cancer Physiology Nagoya University Graduate School of Medicine Nagoya Japan

Funder

Japan Society for the Promotion of Science

Takeda Science Foundation

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15069

Reference31 articles.

1. Global cancer statistics

2. HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition

3. Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells

4. Regulation of CD45 Alternative Splicing by Heterogeneous Ribonucleoprotein, hnRNPLL

5. The basics of epithelial-mesenchymal transition

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with TMB in pancreatic cancer;Journal of Cancer;2024

2. HNRNPLL is a Prognostic Biomarker Associated with Hepatocellular Carcinoma Immune Infiltration and Related to Migration of Hepatocellular Carcinoma Cells;2023-04-19

3. Exploring the Novel Computational Drug Target and Associated Key Pathways of Oral Cancer;Current Issues in Molecular Biology;2022-08-09

4. Comprehensive Analysis of the Expression and Prognosis for the DREAM Complex in Human Cancers;Frontiers in Genetics;2022-05-12